FDA Warns J&J Unit Over Joint Product Marketing
The U.S. Food and Drug Administration has warned Johnson & Johnson's DePuy Orthopaedics Inc. unit that two of its artificial joint products are being sold without required marketing approval and clearance....To view the full article, register now.
Already a subscriber? Click here to view full article